---
document_datetime: 2023-09-21 19:12:18
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/hexavac-epar-all-authorised-presentations_en.pdf
document_name: hexavac-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.0375746
conversion_datetime: 2025-12-20 01:11:48.725242
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
<!-- image -->

| EU Number       | Invented name   | Strength   | Pharmaceutical form                | Route of administration   | Packaging                             | Content   |
|-----------------|-----------------|------------|------------------------------------|---------------------------|---------------------------------------|-----------|
| EU/1/00/147/001 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/002 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use         | pre-filled syringe (glass) authorised | 0.5 ml    |
| EU/1/00/147/003 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/004 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/005 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/006 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/007 | Hexavac         | - 1 -      | Suspension for                     | Intramuscular use longer  | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/008 | Hexavac         | - 1 -      | injection Suspension for injection | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/009 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use no      | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/010 | Hexavac         | - 1 -      | Suspension for injection           | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/011 | Hexavac         | - 1 -      | Suspension for injection product   | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |
| EU/1/00/147/012 | Hexavac         | - 1 -      | Suspension for                     | Intramuscular use         | pre-filled syringe (glass)            | 0.5 ml    |

1 Monodose preparation of 0.5 ml contains: Purified diptheria toxoid, adsorbed (PDT) Purified tetanus toxoid, adsorbed (PTT)

injection

≥ 20 IU ≥ 40 IU Medicinal product no longer authorised

## Package size

1 syringe with attached needle 10 syringes with attached needle 25 syringes with attached needle 50 syringes with attached needle 1 syringe without attached needle 10 syringes without attached needle 25 syringes without attached needle 50 syringes without attached needle 1 syringe without attached needle with 1 separate needle 1 syringe without attached needle with 2 separate needles 10 syringes without attached needle with 1 separate needle 10 syringes without attached needle with 2 separate needles

<div style=\"page-break-after: always\"></div>

| Purified pertussis toxoid, adsorbed (PTxd)         | 25 µg      |
|----------------------------------------------------|------------|
| Purified filamentous haemagglutinin adsorbed (FHA) | 25 µg      |
| Recombinant hepatitis B surface antigen, S (HBsAg) | 5.0 µg     |
| Inactivated poliomyelitis virus (IPV):             |            |
| type 1                                             | 40 D units |
| type 2                                             | 8 D units  |
| type 3                                             | 32 D units |
| Haemophilus influenzae polysaccharide type b       | 12 µg      |
| conjugated to tetanus protein (PRP-T)              | 24 µg      |

<!-- image -->